Selegiline Alleviates the Depressive-Like Behaviors of Methamphetamine Withdrawal Syndrome Through Modulating Mitochondrial Function and Energy Hemostasis

Background: Methamphetamine (METH) is considered the second most commonly abused drug in the world. There is limited or no evidence concerning the effective treatment of METH withdrawal symptoms, such as depression and anxiety. Mode of action of selegiline (increase of the brain neurotransmitter act...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Mir-Jamal Hosseini, Sima Askari Sadat-Mahaleh, Hamed Ghavimi
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Tabriz University of Medical Sciences 2022-04-01
Edice:	Pharmaceutical Sciences
Témata:	selegiline methamphetamine depression mitochondrion oxidative stress fluoxetine
On-line přístup:	https://ps.tbzmed.ac.ir/PDF/ps-28-251.pdf
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!